Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zhongzhi Pharmaceutical Holdings Limited ( (HK:3737) ) just unveiled an update.
Zhongzhi Pharmaceutical Holdings Limited reported its financial results for the year ended December 31, 2024, showing an 8% increase in revenue to RMB 2,214,783,000 compared to the previous year. However, the company experienced a significant decline in profit attributable to equity holders, which fell by 41.5% to RMB 95,212,000, primarily due to increased selling and distribution expenses.
More about Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited, incorporated in the Cayman Islands, operates in the pharmaceutical industry, focusing on the production and distribution of medicinal products.
YTD Price Performance: -6.06%
Average Trading Volume: 302,929
Technical Sentiment Signal: Buy
Current Market Cap: HK$787.7M
Find detailed analytics on 3737 stock on TipRanks’ Stock Analysis page.